Anticorps Monoclonal anti-ARHGDIB

ARHGDIB Monoclonal Antibody for WB, IHC, IF-P, Indirect ELISA

Hôte / Isotype

Mouse / IgG2b

Réactivité testée

Humain, rat, souris

Applications

WB, IHC, IF-P, Indirect ELISA

Conjugaison

Non conjugué

CloneNo.

3E7B7

N° de cat : 66054-1-PBS

Synonymes

3E7B7, GDIA2, GDID4, Ly GDI, Ly-GDI



Informations sur le produit

66054-1-PBS cible ARHGDIB dans les applications de WB, IHC, IF-P, Indirect ELISA et montre une réactivité avec des échantillons Humain, rat, souris

Réactivité Humain, rat, souris
Hôte / Isotype Mouse / IgG2b
Clonalité Monoclonal
Type Anticorps
Immunogène ARHGDIB Protéine recombinante Ag9091
Nom complet Rho GDP dissociation inhibitor (GDI) beta
Masse moléculaire calculée 201 aa, 23 kDa
Poids moléculaire observé 27 kDa
Numéro d’acquisition GenBankBC009200
Symbole du gène ARHGDIB
Identification du gène (NCBI) 397
Conjugaison Non conjugué
Forme Liquide
Méthode de purification Purification par protéine G
Tampon de stockage PBS only
Conditions de stockageStore at -80°C. 20ul contiennent 0,1% de BSA.

Informations générales

ARHGDIB, also known as RhoGDI2, is a conserved member of the RhoGDI family and plays an important role in cell migrations. It regulates the GDP/GTP exchange reaction of the Rho proteins by inhibiting the dissociation of GDP from them, and the subsequent binding of GTP to them. It is mainly in hematopoietic, endothelial, and epithelial cells. It has been linked to tumorigenesis and metastasis. RhoGDI2 expression is downregulated in several cancer types, such as bladder, lung and lymphoma, but is upregulated in prostate and gastric cancer.

{{ptg:RelatedPrimaryAntibodies}}